Bibliografias temáticas / Yibin Shi yi zhong

Índice

  1. Artigos de revistas
  2. Teses / dissertações
  3. Livros

Literatura científica selecionada sobre o tema "Yibin Shi yi zhong"

Autor: Grafiati
Publicado: 29 de julho de 2024
Última modificação: 30 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Yibin Shi yi zhong".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Artigos de revistas sobre o assunto "Yibin Shi yi zhong"

1

Zhenglang, Zhang. "11. A Brief Discussion on Fu Hao". Early China 9, S1 (1986): 21–22. http://dx.doi.org/10.1017/s0362502800002984.

Texto completo da fonte
Resumo:
ABSTRACT(N.B. A version of this paper has now been published in Kaogu 1983.6:537-41.)Fu Hao (or Fu Zi ) appears in the oracle-bone inscriptions from Anyang. The name is often seen in Period I inscriptions (from the time of Wu Ding) and occasionally in Period IV inscriptions (from the time of Wu Yi and Wen Ding). The two are separated by four kings (Zu Geng, Zu Jia, Lin Xin, and Kang Ding), perhaps by as much as one hundred years. Does the Fu Hao in both periods refer to the same person? How can we explain this phenomenon?In the oracle-bone records of people and their activities there are cases where one figure is active in different periods. These names are often also place names, and these figures possess a populace and products. These names are probably what is termed “Clan-Territory titles” (a term found in the Gu shi kao, as quoted in the “Zheng yi” commentary to the Zuo zhuan). Based on their clan name they served hereditarily as officials. These clan names occur in historical literature, as in “In the past, our former kings were for generations Lords of Millet (Hou Ji ), serving under the Yü and Xia “(Guo yü “Zhou Yü” ); or “The Zhong and Li clans generation after generation ordered heaven and earth, … the Sima clan for generation after generation was in charge of the history of Zhou” (Shi ji, “Taishigong zixu” ).
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Wu, Fusheng. "Tang shi xi chuan shi lun: Yi Tang shi zai Ying Mei de chuan bo wei zhong xin 唐诗西传史论 (review)". China Review International 18, n.º 1 (2011): 76–77. http://dx.doi.org/10.1353/cri.2011.0025.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

N., W. H., Yeh Kuei-kang (Ye Gui gang) e Wang Kuei-yuan (Wang Gui yuan). "Chung-kuo ku-tai shih ta i-shih hsiao-shuo shang-hsi (Zhong guo gu dai shi da yi shi xiao shuo shang xi). 2v". Chinese Literature: Essays, Articles, Reviews (CLEAR) 18 (dezembro de 1996): 236. http://dx.doi.org/10.2307/495651.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Kiyohara, H., T. Nagai, K. Munakata, K. Nonaka, T. Hanawa, J. Kim e H. Yamada. "Stimulating Effect of Japanese Herbal (Kampo) Medicine, Hochuekkito on Upper Respiratory Mucosal Immune System". Evidence-Based Complementary and Alternative Medicine 3, n.º 4 (2006): 459–67. http://dx.doi.org/10.1093/ecam/nel030.

Texto completo da fonte
Resumo:
Japanese herbal (Kampo) medicine, Hochuekkito (Bu-Zhong-Yi-Qi-Tang in Chinese, TJ-41) and Juzentaihoto (Shi-Quan-Da-Bu-Tang in Chinese, TJ-48) are well-known Kampo formulas used as tonic. Although these medicines have separately been applied to the patients clinically depending on their symptoms, the differences of the pharmacological activities for these medicines have not been fully understood. TJ-48 and TJ-41 were compared for their effects on antibody response in upper respiratory mucosal immune systemin vivo. Oral administration of TJ-41 (100 mg kg-1 per day) to early aged BALB/c mice, which were nasally sensitized with influenza hemagglutinin vaccine, significantly enhanced influenza virus-specific IgA and IgG antibody titers in nasal cavity and sera, respectively. However, oral administration of TJ-48 (100 mg kg-1 per day) failed to show the enhancing activity. TJ-41 increased not only influenza virus-specific IgA antibody titer but also total IgA antibody titer in nasal cavity. The stimulating activity of TJ-41 disappeared after treatment with methotrexate. The present study strongly suggests that TJ-41 can stimulate the mucosal immune system of upper respiratory tract, and results in enhancement of antigen-specific antibody response in upper respiratory mucosal and systemic immune systems.
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Mita, Y., K. Dobashi, Y. Shimizu, T. Nakazawa e M. Mori. "Surface expression of toll-like receptor 4 on THP-1 cells is modulated by Bu-Zhong-Yi-Tang and Shi-Quan-Da-Bu-Tang". Methods and Findings in Experimental and Clinical Pharmacology 24, n.º 2 (2002): 67. http://dx.doi.org/10.1358/mf.2002.24.2.677128.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Shi, Qiyun, Xiaowei Qi, Peng Tang, Linjun Fan, Li Chen, Shushu Wang, Guozhi Zhang et al. "Abstract OT2-22-01: Epirubicin, cyclophosphamide and pyrotinib followed by docetaxel, trastuzumab and pyrotinib as neoadjuvant therapy for stage II-III HER2-positive breast cancer: a single-arm, multicenter phase 2 trial". Cancer Research 83, n.º 5_Supplement (1 de março de 2023): OT2–22–01—OT2–22–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-ot2-22-01.

Texto completo da fonte
Resumo:
Abstract Background: Dual HER2 targeted therapy with pyrotinib (a tyrosine kinase inhibitor targeting HER1, HER2, and HER4) and trastuzumab plus chemotherapy has been approved as neoadjuvant therapy for patients with HER2-positive breast cancer in China based on the results from phase 3 PHEDRA study. However, the optimal chemotherapy partner still needs exploration. This multicenter phase 2 trial (ChiCTR1900022293) aimed to investigate the efficacy and safety of epirubicin, cyclophosphamide and pyrotinib followed by docetaxel, trastuzumab and pyrotinib (ECP-THP) as neoadjuvant therapy for patients with stage II-III HER2-positive breast cancer. Methods: Patients received intravenous epirubicin (90 mg/m2) and cyclophosphamide (600 mg/m2) on day 1 of each cycle for four 21-day cycles, followed by intravenous docetaxel (75 mg/m2) and trastuzumab (8 mg/kg loading dose, followed by 6 mg/kg) on day 1 for 4 cycles. Pyrotinib 400 mg was given orally once daily throughout the neoadjuvant therapy period. Surgery was performed within 16-20 days after the last neoadjuvant therapy. The primary endpoint was total pathological complete response (tpCR, ypT0/is ypN0) rate. Results: Between May 2020 and May 2022, a total of 175 patients enrolled. As of May 31, 2022, 144 patients had undergone surgery; the median age was 51 years (range, 26-67). Sixty-seven (46.5%) of 144 patients had hormone receptor (HR)-negative disease, and 77 (53.5%) had HR-positive disease. The tpCR rate was 67.4% (97/144; 95%CI, 59.3%-74.5%). Patients with HR-negative disease had numerically higher tpCR rate than those with HR-positive disease (73.1% [95%CI, 61.5%-82.3%] vs. 62.3% [95%CI, 51.2%-72.3%]), but without statistical significance (P=0.230). Miller-Payne grade 4 and 5 pathological responses were found in 22 (15.3%) and 97 (67.4%) of 144 patients, respectively. Regarding clinical response to neoadjuvant therapy before surgery, 31 (21.5%) of 144 patients achieved complete response and 99 (68.8%) achieved partial response, with an objective response rate of 90.3% (95%CI, 84.3%-94.1%). Of 161 patients with available safety data, the most common grade ≥3 adverse events included diarrhea (57.1%), white blood cell count decreased (8.7%), and neutrophil count decreased (5.6%). No treatment-related deaths occurred. Conclusions: Patients with stage II-III HER2-positive breast cancer show favorable clinical and pathological response to this ECP-THP neoadjuvant regimen, with an acceptable safety profile. Citation Format: Qiyun Shi, Xiaowei Qi, Peng Tang, Linjun Fan, Li Chen, Shushu Wang, Guozhi Zhang, Mengyuan Wang, Hongying Che, Pengwei Lv, Dejie Chen, Jinhui Hu, Qiuyun Li, Yanwu Zhang, Qiao Yu, Kunxian Yang, Yuan Zhong, Chuang Chen, Zemin Zhou, Liyuan Qian, Jingwei Zhang, Mingde Ma, Yi Sun, Jiangbo Liu, Yi Zhang, Jun Jiang. Epirubicin, cyclophosphamide and pyrotinib followed by docetaxel, trastuzumab and pyrotinib as neoadjuvant therapy for stage II-III HER2-positive breast cancer: a single-arm, multicenter phase 2 trial [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr OT2-22-01.
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Sato, M. "Bei Yi-hui de Ge-ming Qing-jie--Zai Zhong-ri Liang-guo Cong-shi Ge-ming de Li-cheng (Kita Ikki's Radical Complex: The Course of His Involvement in Chinese and Japanese Revolutions), by Huang Tzu-chin. Taipei: Academia Sinica, 2001, 350 pp., NT$350 (hardcover ISBN 957-671-755-8), 341 pp., NT$300 (paperback ISBN 957-671-756-6)". Social Science Japan Journal 8, n.º 1 (3 de setembro de 2004): 131–33. http://dx.doi.org/10.1093/ssjj/jyh046.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Wang, Zuoyue. "Jian Zhang. Ke xue she tuan zai jin dai Zhongguo de ming yun: yi Zhongguo ke xue she wei zhong xin [The Science Association and the Change of Society in Modern China: A Study on the Science Society of China]. (Zhongguo jin xian dai ke xue ji shu shi yan jiu cong shu.). 460 pp., tables, bibl., index. Jinan: Shandong jiao yu chu ban she [Shandong Education Press], 2005. ¥49 (paper)." Isis 99, n.º 2 (junho de 2008): 437–38. http://dx.doi.org/10.1086/591376.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

WEI, Ran, e Zuozhen HUANG. "From Research on TCM Images to Historiography of TCM Images——Comments on History of Chinese Image Culture: Medical Image Volume". Chinese Medicine and Culture, 10 de julho de 2024. http://dx.doi.org/10.1097/mc9.0000000000000108.

Texto completo da fonte
Resumo:
Abstract Zhong Hua Tu Xiang Wen Hua Shi Yi Yao Tu Xiang Juan (《中华图像文化史•医药图像卷》History of Chinese Image Culture: Medical Image Volume) is a history of images of Chinese medicine. This work meticulously traces the evolution of Chinese medicine from the pre-Qin and Han dynasties through to the late Qing dynasty and the Republican era, utilizing a rich array of medical and non-medical images. Through detailed analysis and interpretation of these images, the volume reconstructs the developmental trajectory of traditional Chinese medicine (TCM) theories, while also revealing the impact of ideological, cultural, and societal contexts on medical culture and theoretical advancement. Zhong Hua Tu Xiang Wen Hua Shi Yi Yao Tu Xiang Juan has pushed the research of Chinese medical images from purely literary studies to a broader historical context, broadened the research object of Chinese medical history, and constructed a basic framework for the new research field of image medical history. The book not only facilitates a deeper understanding of TCM's historical and contemporary developments, but also holds significant value for scholars engaged in historical literature research or clinical practice, aiming to integrate historical insights.
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Kósa, Gábor. "Kultúrhéroszok vagy hivatalnokok". Távol-keleti Tanulmányok 10, n.º 2018/1 (30 de março de 2019). http://dx.doi.org/10.38144/tkt.2018.1.2.

Texto completo da fonte
Resumo:
The 17th book of Lüshi chunqiu 呂氏春秋, compiled by Lü Buwei 呂不韋 inthe 3rd c. B.C., comprises two lists of officials who are credited with initiatingcertain cultural phenomena. In this study, I explore the available informationon these 26 individuals (Da Nao 大橈, Qian Ru 黔如, Rong Cheng 容成, XiHe 羲和, Shang Yi 尚儀, Hou Yi 后益, Hu Cao 胡曹, Yi Yi 夷羿, Zhu Rong祝融, Yi Di 儀狄, Gao Yuan 高元, Yu Xu 虞姁, Bo Yi 伯益, Chi Ji 赤冀, ChengYa 乘雅, Han Ai 寒哀, Wang Hai 王亥, Shi Huang 史皇, Wu Peng 巫彭, WuXian巫咸, Xi Zhong 奚仲, Cang Jie 蒼頡, Houji 后稷, Gao Yao 皋陶, Kunwu昆吾, Gun 鯀), and propose a new interpretation of their presence in this earlysource.
Estilos ABNT, Harvard, Vancouver, APA, etc.

Teses / dissertações sobre o assunto "Yibin Shi yi zhong"

1

Yan, Caiqin. "17 shi ji zhong qi zhi19 shi ji chu yue nan hua yi yan jiu(1640-1802)". Xiamen : Xiamen da xue, 2007. http://anulib.anu.edu.au/anuonly/ebooks/chinese_thesis_031.pdff.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Li, Zhiwen. "Guang yi xiu ci zai zhong liu Zhong wen ke shi yong wen zhi jiao cai she ji /". click here to view the abstract and table of contents, 1996. http://net3.hkbu.edu.hk/~libres/cgi-bin/thesisab.pl?pdf=b14945678a.pdf.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Huang, Yuyun. "Wu shi Zhong yi shou fa zhi liao yao tong de lin chuang yan jiu /". click here to view the abstract and table of contents, 2006. http://net3.hkbu.edu.hk/~libres/cgi-bin/thesisab.pl?pdf=b20009495a.pdf.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Chen, Xiaoming. "Lei feng shi xing guan jie yan de Zhong yi lin chuang yan jiu jin zhan /". click here to view the abstract and table of contents, 2006. http://net3.hkbu.edu.hk/~libres/cgi-bin/thesisab.pl?pdf=b19986245a.pdf.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Wong, Ching-yung. "The choice of medium of instruction and its implications for CMI schools : case study = Chu zhong yi zhong wen shou ke de zhong xue zhong si ji jiao xue yu yan de xuan ze ji shi shi : ge an yan jiu /". Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25248844.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Chan, Kung Fong. "Cong jiao yu zhong "gai zao" nü xing : yi "Guangdong Sheng li di yi nü zi shi fan xue xiao" wei ge an yan jiu (1907-1938) /". View abstract or full-text, 2004. http://library.ust.hk/cgi/db/thesis.pl?HUMA%202004%20CHAN.

Texto completo da fonte
Resumo:
Thesis (M.Phil.)--Hong Kong University of Science and Technology, 2004.
Includes bibliographical references (leaves 323-342). Also available in electronic version. Access restricted to campus users.
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Kam, Kin-kei. "The social awareness of Shen Congwen's (1902-1988) Xiangxi fictions / Shen Congwen xiang xi xiao shuo zhong de she hui yi shi". Hong Kong : University of Hong Kong, 1999. http://sunzi.lib.hku.hk:8888/cgi-bin/hkuto%5Ftoc%5Fpdf?B22752833.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Ming, Yau-yau. "Qing poetry on Ming a historical perspective focusing on the writing on Ming Yuefu = Qing zhao yong Ming shi ji de shi xue shen shi : yi Ming yue fu de zhuan shu wei zhong xin /". Click to view the E-thesis via HKUTO, 2010. http://sunzi.lib.hku.hk/hkuto/record/B44204723.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Mu, Jian. "Zhuzi de shi li guan ji qi yu li de guan xi zhi yan jiu : yi Zhuzi "Si shu" xue wei zhong xin /". View abstract or full-text, 2008. http://library.ust.hk/cgi/db/thesis.pl?HUMA%202008%20MU.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Wang, Lianghe. "Shi guan de chong tu yu zhu liu de jing zhu : Xianggang ba, jiu shi nian dai shi tan de liu pai fen zheng--yi "Zhong Weimin xian xiang" ying zhao = The clash of poetic views and striving to be the centre : an exploration of the conflict between poetic schools in the 1980s and 90s in Hong Kong in the light of the "Chung Wai Man phenomenon" /". click here to view the abstract and table of contents, 2001. http://net3.hkbu.edu.hk/~libres/cgi-bin/thesisab.pl?pdf=b17040474a.pdf.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Livros sobre o assunto "Yibin Shi yi zhong"

1

Yibin Shi yi zhong xiao zhi bian ji shi. 宜宾市一中校志, 1901-2001. Yibin Shi]: Yibin Shi yi zhong xiao zhi bian ji shi, 2001.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Zhongguo ren min zheng zhi xie shang hui yi. Yibin Shi wei yuan hui. Di 11 jie chang wei hui. Yibin Shi zheng xie zhi: Xu zhi (1989-1997). [Yibin Shi]: Zheng xie Yibin Shi wei yuan hui di 11 jie chang wei hui, 1997.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Hua, Yu. Xian shi yi zhong. Taibei Shi: Mai tian chu ban, 2006.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Hua, Yu. Xian shi yi zhong. Shanghai: Shanghai wen yi chu ban she, 2004.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Tiecheng, Huang, Zhao Heling e Zhang Mingcheng, eds. Zhong Ri shi yi. Xi'an: Shanxi ren min chu ban she, 1995.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Peng, Junsheng. Zhong yi yi an shi lu. Xianggang: Jing ji ri bao chu ban she, 2006.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Shiran, Yu, ed. Zhong yi shi liao yao shan: Zhong yi shi liao yao shan. Beijing Shi: Zhao hua chu ban she, 2006.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Ge, Jianxiong. Zhong guo yi min shi. Fuzhou Shi: Fujian ren min chu ban she, 1997.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Mengda, Shu, e Jiang Haishen, eds. Zhong yi shi shou ce. Beijing: Beijing ke xue ji shu chu ban she, 1986.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Wu, Songdi. Zhong guo yi min shi. Fuzhou Shi: Fujian ren min chu ban she, 1997.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes
Você também pode estar interessado nas extensas listas de trabalhos sobre o assunto "Yibin Shi yi zhong":
Teses / dissertações Livros
Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!

Vá para a bibliografia